Something Old, Something New: What is a 505(b)2?
We explore the 505(b)2 pathway for expedited approval of previously-approved active drug ingredients with new formulations.
The FDA Could Approve Almost Any Drug (But It Won’t Approve That)
We discuss the role of the FDA in the drug approval process and their recent approval of the controversial Alzheimer’s drug, Aduhelm.